How cell crowding influences nanoparticle uptake
In the human body, cells are rarely arranged in perfect uniformity. In healthy tissues, cell density can vary depending on the organ and its function; in tumors, this variability can become even more pronounced. These natural differences in cell crowding influence how cells behave, and a new NCCR Bio-Inspired Materials study suggests they also affect how cells take up nanoparticles, with potential implications for drug delivery and cancer treatment.
“Scientists usually study nanoparticle‑cell interactions in cultures where cells are evenly distributed, and then make general assumptions,” says NCCR principal investigator Barbara Rothen-Rutishauser, professor of BioNanomaterials at the Adolphe Merkle Institute, who co-led the study. “But in nature, cell gradients are common, so we wanted to mimic these gradients in the lab to better understand their effect on cell behavior in the presence of nanoparticles.”
To do this, Rothen-Rutishauser’s group teamed up with the team of NCCR principal investigator Alke Fink, also a professor of BioNanomaterials at the Adolphe Merkle Institute, in a project that blends expertise in cell biology and nanoparticle engineering.
Luigi Di Stolfo, a PhD student with Rothen-Rutishauser, optimized a method that uses bioprinting to create cell density gradients of lung epithelial cells in a single culture dish — a task that remains challenging with traditional methods. He then exposed these cells to silica nanoparticles incorporating a fluorescent dye to track their uptake using advanced fluorescence imaging.
Cells in lower‑density regions took up about 50% more nanoparticles than those in higher‑density areas, even 48 hours after exposure, the researchers found. This difference was not due to cell growth rates but rather linked to changes in cell shape and surface contact.
“If you have lower density, you have a bigger surface in contact with particles,” Rothen-Rutishauser says. “The cell density influences both cell behavior and nanoparticle interaction.” The researchers published their findings in Frontiers of Bioengineering and Biotechnology.
The work opens exciting possibilities. While the team began with a two‑dimensional cell gradient, their next goal is to explore three‑dimensional models. Because tumors often have high cell density in the center and lower density at the edges, this pattern could influence how nanoparticle drug carriers behave. This aspect, Rothen-Rutishauser says, could help advance cancer therapy.
While the method is powerful, Rothen-Rutishauser notes that not every laboratory has access to a bioprinter because of the cost and technical challenges. However, once a protocol is established, the bioprinting approach is reproducible and could be adapted to print different cell types in defined densities and with spatial control. This flexibility could make it relevant for studies on inflammation, wound healing, or tumor growth, Rothen-Rutishauser says.
The project reflects the collaborative spirit of the NCCR. “This idea emerged through discussions with different people in the network—without the NCCR, we would not have thought of it,” Rothen-Rutishauser says. The work, she adds, has already attracted attention from other researchers. “We have already got a lot of emails saying, ‘this is interesting, we’ll follow up on this."
Reference: Di Stolfo, L.; Lee, W. S.; Vanhecke, D.; Balog, S.; Taladriz-Blanco, P.; Petri-Fink, A.; Rothen-Rutishauser, B. The Impact of Cell Density Variations on Nanoparticle Uptake across Bioprinted A549 Gradients. Front. Bioeng. Biotechnol. 2025, 13. https://doi.org/10.3389/fbioe.2025.1584635
